Musa Tariq Guardant Health, Inc. (GH) insider trading activity

GH Quotes by TradingView

Musa Tariq is Director of Guardant Health, Inc.. Currently has a direct ownership of 7,190 shares of GH, which is worth approximately $363,095. The most recent transaction as insider was on Jun 18, 2025, when has been sold 3,213 shares (Common Stock) at a price of $49.47 per share, resulting in proceeds of $158,947. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.19K
123.92% 3M change
91.89% 12M change
Total Value Held $363,095

Musa Tariq Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
SELL
Open market or private sale
$158,947 $49.47 p/Share
3,213 Reduced 30.89%
7,190 Common Stock
Jun 15 2025
BUY
Exercise of conversion of derivative security
-
250 Added 2.35%
10,403 Common Stock
Jun 12 2025
BUY
Exercise of conversion of derivative security
-
6,674 Added 39.66%
10,153 Common Stock
May 19 2025
SELL
Open market or private sale
$4,644 $40.04 p/Share
116 Reduced 3.23%
3,479 Common Stock
May 15 2025
BUY
Exercise of conversion of derivative security
-
250 Added 6.5%
3,595 Common Stock
Apr 17 2025
SELL
Open market or private sale
$5,195 $44.79 p/Share
116 Reduced 3.35%
3,345 Common Stock
Apr 15 2025
BUY
Exercise of conversion of derivative security
-
250 Added 6.74%
3,461 Common Stock
Mar 19 2025
SELL
Open market or private sale
$5,069 $43.7 p/Share
116 Reduced 3.49%
3,211 Common Stock
Mar 15 2025
BUY
Exercise of conversion of derivative security
-
249 Added 6.96%
3,327 Common Stock
Feb 20 2025
SELL
Open market or private sale
$5,606 $48.33 p/Share
116 Reduced 3.63%
3,078 Common Stock
Feb 15 2025
BUY
Exercise of conversion of derivative security
-
250 Added 7.26%
3,194 Common Stock
Jan 17 2025
SELL
Open market or private sale
$4,359 $37.58 p/Share
116 Reduced 3.79%
2,944 Common Stock
Jan 15 2025
BUY
Exercise of conversion of derivative security
-
250 Added 7.55%
3,060 Common Stock
Dec 18 2024
SELL
Open market or private sale
$4,042 $34.85 p/Share
116 Reduced 3.96%
2,810 Common Stock
Dec 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 7.87%
2,926 Common Stock
Dec 13 2024
SELL
Open market or private sale
$81,200 $35.0 p/Share
2,320 Reduced 46.44%
2,676 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 4.77%
4,996 Common Stock
Oct 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 5.0%
4,746 Common Stock
Sep 15 2024
BUY
Exercise of conversion of derivative security
-
249 Added 5.25%
4,496 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 5.56%
4,247 Common Stock
Jul 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 5.89%
3,997 Common Stock
Jun 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 6.25%
3,747 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
250 Added 6.67%
3,497 Common Stock
Apr 15 2024
BUY
Exercise of conversion of derivative security
-
249 Added 7.12%
3,247 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
2,998 Added 50.0%
2,998 Common Stock
MT

Musa Tariq

Director
Palo Alto, CA

Track Institutional and Insider Activities on GH

Follow Guardant Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GH shares.

Notify only if

Insider Trading

Get notified when an Guardant Health, Inc. insider buys or sells GH shares.

Notify only if

News

Receive news related to Guardant Health, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GH